Cristel Camacho

Assistant Professor

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Cristel Camacho is an Assistant Professor at the University of Texas Southwestern Medical Center in the United States. Her research focuses on translating molecular mechanisms in gynecologic cancers and breast cancer, with recent articles exploring topics such as RNA helicase DDX21 in cancer survival outcomes and the role of lncRNA152 as a tumor suppressor. Additionally, she investigates ADP-ribosylation and its implications in cancer biology and therapeutic resistance.

Articles (9)

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Laura Banaszynski

Assistant Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Jessica Parker

Assistant Professor of Gynecologic Oncology

Indiana University Bloomington

UNITED STATES

View details

Jayanthi Lea

Associate Professor

University of Texas Southwestern Medical School

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Cristel Camacho

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

RACK1 MARylation regulates translation and stress granules in ovarian cancer cells

Nucleolar Localization of the RNA Helicase DDX21 Predicts Survival Outcomes in Gynecologic Cancers

Development and characterization of recombinant ADP-ribose binding reagents that allow simultaneous detection of mono and poly ADP-ribose

Oncohistone Mutations Occur at Functional Sites of Regulatory ADP-Ribosylation

Functional Characterization of lncRNA152 as an Angiogenesis-Inhibiting Tumor Suppressor in Triple-Negative Breast Cancers

Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo

PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α–Positive Breast Cancer Cells

Alternate therapeutic pathways for PARP inhibitors and potential mechanisms of resistance

Functional Interplay between Histone H2B ADP-Ribosylation and Phosphorylation Controls Adipogenesis

Collaborators (3)

Laura Banaszynski

Jessica Parker

Jayanthi Lea

Make your next move.